1 / 32

PTP 546

PTP 546. Module 6 Cardiovascular Pharmacology: Part I Jayne Hansche Lobert, MS, RN, ACNS-BC, NP. Cardiovascular Pharmacology . Hypertension (HTN) Classification Prehypertension <120-139/80-89 Stage 1 hypertension 140-150/90-99 Stage 2 hypertension > 160/100 Incidence

mircea
Download Presentation

PTP 546

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PTP 546 Module 6 Cardiovascular Pharmacology: Part I Jayne Hansche Lobert, MS, RN, ACNS-BC, NP Lobert

  2. Cardiovascular Pharmacology • Hypertension (HTN) • Classification • Prehypertension <120-139/80-89 • Stage 1 hypertension 140-150/90-99 • Stage 2 hypertension > 160/100 • Incidence • 30% of general population • 51% of African American population • 90% of HTN is considered “essential or primary” Lobert

  3. Cardiovascular Pharmacology • Cardiac Output (CO)= Stroke Volume x Heart Rate • Blood Pressure = CO x Peripheral Vascular Resistance (PVR) Lobert

  4. Cardiovascular Pharmacology • Antihypertensive Drug Classes • Diuretics • Sympatholytic Drugs • Beta Blockers, Mixed Blockers & Centrally Acting Adrenergics • Angiotensin Converting Enzyme (ACE)Inhibitors • Angiotensin Receptor Blockers (ARB) • Calcium Channel Blockers (CCB) • Step Approach to Management of HTN • Lifestyle modification • Classes of drugs added one at a time Lobert

  5. Cardiovascular Pharmacology • Diuretics • Thiazide Diuretics • Hydrocholorothiazide • Chlorothiazide (Diuril) • Loop Diuretics • Bumetanide (Bumex) • Furosemide (Lasix) • Potassium Sparing Diuretics • Spironolactone (Aldactone) • Triamterene (Dyrenium) Lobert

  6. Cardiovascular Pharmacology • Thiazide Diuretics • Ex: Hydrodiuril (Diuril) • Action: Inhibits sodium reabsorption in distal tubules  sodium retention in the nephrons  osmotic water attraction to nephrons  increased renal excretion of fluids • Therapeutic Effect: Reduces Blood Pressure • Side Effect: fluid loss, hypotension, electrolyte loss especially potassium loss  hypokalemia • Loop Diuretics • Ex: Furosemide (Lasix) • Action: Inhibits sodium and chloride reabsorption in nephron  prevents water reabsorption  increased renal excretion of fluids • Therapeutic Effect: Reduces blood pressure • Side Effect: fluid loss, hypotension, dizziness, fatigue, electrolyte loss  especially potassium loss hypokalemia Lobert

  7. Cardiovascular Pharmacology • Potassium Sparing Diuretics • Ex: Spironolactone (Aldactone) • Action: Sodium is reabsorbed in tubules (while potassium is spared)  water reabsorption with increased renal excretion of fluids • Therapeutic Effect: reduction in blood pressure • Side Effects: fluid loss, hypotension, hyponatremia, hyperkalemia with Dysrhythmias Lobert

  8. Cardiovascular Pharmacology • Sympatholytics • Beta Blockers • Atenolol (Tenormin) • Metoprolol (Lopressor) • Propanolol (Inderal) • Nadolol (Corgard) • Mixed Alpha & Beta Blocker • Carvedilol (Coreg) • Centrally Acting Agents • Clonidine (Catapres) Lobert

  9. Cardiovascular Pharmacology • Beta Blockers • Ex: Atenolol (Tenormin); Propanolol (Inderal) • Action: decreases beta receptor stimulation heart rate & cardiac contractility reduction in CO; decreases general sympathetic activity including to peripheral vessels • Therapeutic Effect: reduces blood pressure • Side Effects: hypotension, bradycardia, impaired glucose levels, fatigue, insomnia, activity intolerance, bronchoconstriction, impotence Lobert

  10. Cardiovascular Pharmacology • Mixed Alpha & Beta Blocker • Ex: Carvedilol (Coreg) • Centrally Acting Agents • Ex. Clonodine (Catapres) • Action: inhibits sympathetic discharge from the brainstem  decreased sympathetic receptor stimulus to heart and peripheral vessels • Therapeutic Effect: reduces blood pressure • Side Effects: hypotension, peripheral edema, decreased libido Lobert

  11. Cardiovascular Pharmacology • Angiotension Converting Enzyme Inhibitors (ACE) Inhibitors & Angiotension Receptor Blockers (ARB) • Ex: ACE = Enalopril (Vasotec); Captopril (Capoten) • Ex: ARB = Lorsartan (Cozaar); Lobert

  12. Cardiovascular Pharmacology • Angiotension Converting Enzyme Inhibitors (ACE) Inhibitors & Angiotension Receptor Blockers (ARB) • Ex: ACE = Enalopril (Vasotec); Captopril (Capoten) • Ex: ARB = Lorsartan (Cozaar); • Action: blocks angio I to angio II  prevents vasoconstriction & blocks renin & aldosterone  impairment of fluid retention • Therapeutic Effect: decreased blood pressure • Side Effects: ACE = headache, dizziness, hypotension, persistent dry cough, renal impairment, hyperkalemia • Side Effect: ARB = same side effects….. except less cough Lobert

  13. Cardiovascular Pharmacology • Calcium Channel Blockers (CCB) • Ex: Amlodipine (Norvasc); Diltiazem (Cardizem); Nifedipine (Adalat); Verapamil (Calan) • Action: blocks the entry of calcium into vascular smooth muscle  vasodilation and reduced pvr • Therapeutic Effect: reduces blood pressure • Side Effects: hypotension, edema in ankles and feet; dizziness, weakness, Dysrhythmias, myalgias, arthralgias Lobert

  14. Cardiovascular Pharmacology • Angina • Chest pain associated with cardiac ischemia • Presents differently in men and women • Oxygen supply to tissues do not meet oxygen demand; metabolites build up  pain • Precipitators: physical and/or emotional exertion Lobert

  15. Cardiovascular Pharmacology • Drugs used to treat Angina • Nitrates • Fast Acting: Nitroglycerin (Nitro Stat) • Long Acting: Nitroglycerin (Nitro Dur, NitroBid); Isosorbide Dinitrate (Isordil) • Beta Blockers • Propanolol (Inderal) • Calcium Channel Blockers • Continuous Release: Nifedipine (Procardia XL) Lobert

  16. Cardiovascular Pharmacology • Nitrates • Ex: Nitroglycerine (Nitro Stat) • Ex: Nitroglycerine (Nitrodur Patch) • Action: potent vasodilator in vascular smooth muscle • Therapeutic Effect: coronary vasodilation and reduction in chest pain • Side Effect: headache, postural hypotension, facial flushing, dizziness Lobert

  17. Cardiovascular Pharmacology • Beta Blockers • Action: blocks sympathetic output  decreases heart rate & decreases contractility  reduction in cardiac workload (less oxygen demand) • Therapeutic Use: treatment of stable angina • Calcium Channel Blockers • Action: relaxes vascular & coronary smooth muscles  less vascular resistance  less cardiac workload  less oxygen demand • Therapeutic Use: treatment of angina Lobert

  18. Cardiovascular Pharmacology • Arrhythmias • Sinus • Ex: sinus bradycardia; sinus tachycardia • Supraventricular • Ex: atrial fibrillation with rapid ventricular response • Atrioventricular Junctional • Ex: junctional rhythm • Conduction Disturbances: • Ex: heart blocks • Ventricular • Ex: V tachycardia, V fibrillation Lobert

  19. Cardiovascular Pharmacology • Classification of Antiarrhythmic Drugs • Class I: Sodium Channel Blockers • Subclass A: Procainamide (Pronestyl) • Subclass B: Lidocaine • Sub Class C: Propafenone (Rythmol) • Class II: Beta Blockers • Ex: Propranolol (Inderal) • Class III: Drugs that prolong repolarization • Ex: Amiodarone (Cordarone) • Class IV: Calcium Channel Blockers • Ex: Verapmil (Calan) Lobert

  20. Cardiovascular Pharmacology • Class I Antiarrhythmics • Class I: Sodium Channel Blockers • Subclass A: Procainamide (Pronestyl) • Subclass B: Lidocaine • Sub Class C: Propafenone (Rythmol) • Action: alter depolarization and repolarization of cardiac cells • Therapeutic Effect: primary treatment of ventricular arrhythmias • Side Effects: increased arrhythmias; dizziness; visual disturbances Lobert

  21. Cardiovascular Pharmacology • Class II Antiarrhythmic • Class II: Beta Blockers • Ex: Propranolol (Inderal) • Action: decrease stimulation of sympathetic nervous system beta receptors  slowing of conduction in the heart and decreased heart rate • Therapeutic effect: primarily used to treat atrial tachycardia's • Side effects: bradycardia; increase in other arrhythmias; bronchoconstriction Lobert

  22. Cardiovascular Pharmacology • Class III Antiarrhythmic Drugs • Class III: Drugs that prolong repolarization • Ex: Amiodarone (Cordarone) • Action: delay repolarization of cardiac cells slowing and stabilization of heart rate • Therapeutic effect: primarily used to treat ventricular arrhythmias • Side effects: increase in arrhythmias; liver toxicity Lobert

  23. Cardiovascular Pharmacology • Class IV Antiarrhythmic Drugs • Class IV: Calcium Channel Blockers • Ex: Verapamil (Calan) • Action: blocks calcium entry into cardiac cells  decreased conduction and excitability of cardiac cells • Therapeutic effect: primarily used to treat atrial arrhythmias • Side effects: bradycardia, dizziness; headaches Lobert

  24. Cardiovascular Pharmacology • Heart Failure • The heart is unable to pump a sufficient blood supply to meet the demands of the body • Chronic condition effects 5 million+ individuals • Prevalence increases with age • One of the most common causes for hospitalization • High incidence of rapid readmission following discharge Lobert

  25. Cardiovascular Pharmacology • Pathophysiology of Heart Failure Lobert

  26. Cardiovascular Pharmacology Right Sided Heart Failure Left Sided Heart Failure Cough & frothy sputum Weight gain Difficulty breathing Dyspnea Orthopnea Abnormal lung sounds Pleural effusion Weakness Fatigue Confusion, Restlessness • Weight gain • Peripheral edema • Enlarged liver • Abdominal pain • Neck vein distention • Weakness • Fatigue • Nausea Lobert

  27. Cardiovascular Pharmacology • Heart Failure Treatment Goals • Improve activity tolerance • Improve oxygenation • Maintain and/or improve quality of life • Pharmacologics can improve the hearts pumping ability by: • Increasing the force of myocardial contractions • Decreasing the workload of the myocardium Lobert

  28. Cardiovascular Pharmacology • Agents that decrease cardiac workload • ACE Inhibitors • Ex: Captopril (Capoten); Lisinopril (Prinivil); Enalapril (Vasotec) • Action: • Therapeutic Effect: • Side Effects: Lobert

  29. Cardiovascular Pharmacology • Agents that decrease cardiac workload • Beta Blockers • Ex: Carvediol (Coreg); Metoprolol (Lopressor) • Action: • Therapeutic Effect: • Side Effects: Lobert

  30. Cardiovascular Pharmacology • Agents that decrease cardiac workload • Diuretics • Ex: Furosemide (Lasix); Hydrodiuril (Diuril); Spironolactone (Aldactone) • Action: • Therapeutic Effect: • Side Effects: Lobert

  31. Cardiovascular Pharmacology • Agents that decrease cardiac workload • Nitrates • Ex: Isosorbide Dinitrate (Isordil) • Action: • Therapeutic Effect: • Side Effects: Lobert

  32. Cardiovascular Pharmacology • Agents that increase the force of the myocardial contractions • Cardioglycosides • Ex: Digoxin (Lanoxin) • Action: increases intracellular calcium  enhanced cardiac contractility; inhibits sympathetic activity normalized conduction  decreased heart rate • Therapeutic Effect: positive inotrope and negative chronotrope contributes to therapeutic usefulness in heart failure • Side Effects: bradycardia, gi disturbances, fatigue, malaise, weakness Lobert

More Related